45 | Proteins (Proteins, Gene)FDA Link
06/2024
-
02/2004 |
21 | Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2024
-
10/2007 |
13 | Peptides (Polypeptides)IBA
01/2024
-
06/2008 |
10 | Anti-Bacterial Agents (Antibiotics)IBA
05/2023
-
01/2017 |
10 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
10/2022
-
11/2014 |
9 | IntegrinsIBA
06/2023
-
07/2013 |
9 | VaccinesIBA
05/2023
-
05/2012 |
9 | Biomarkers (Surrogate Marker)IBA
01/2022
-
06/2018 |
8 | CytokinesIBA
01/2022
-
08/2011 |
7 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
01/2020
-
11/2014 |
6 | DNA (Deoxyribonucleic Acid)IBA
04/2024
-
10/2004 |
6 | AntibodiesIBA
05/2023
-
01/2016 |
6 | Neutralizing AntibodiesIBA
10/2020
-
02/2011 |
6 | Small Interfering RNA (siRNA)IBA
01/2020
-
12/2012 |
6 | ErbB Receptors (EGF Receptor)IBA
01/2017
-
12/2007 |
5 | Radioisotopes (Radionuclides)IBA
05/2024
-
01/2019 |
5 | Therapeutic UsesIBA
04/2024
-
01/2006 |
5 | Interleukin-6 (Interleukin 6)IBA
04/2024
-
02/2019 |
5 | RNA (Ribonucleic Acid)IBA
11/2023
-
04/2018 |
5 | TNF Receptor-Associated Factor 6 (TRAF6)IBA
01/2022
-
01/2016 |
5 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021
-
01/2006 |
5 | Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2017
-
03/2010 |
4 | Reactive Oxygen Species (Oxygen Radicals)IBA
04/2024
-
07/2015 |
4 | 68Ga-FAPIIBA
01/2024
-
01/2021 |
4 | FAPI-46IBA
01/2024
-
10/2022 |
4 | RadiopharmaceuticalsIBA
12/2023
-
12/2014 |
4 | Monoclonal AntibodiesIBA
07/2021
-
01/2006 |
4 | Messenger RNA (mRNA)IBA
03/2021
-
03/2015 |
4 | Tyrosine Kinase InhibitorsIBA
02/2021
-
07/2015 |
4 | Immunoglobulin G (IgG)IBA
01/2020
-
01/2013 |
4 | Cadherins (E-Cadherin)IBA
10/2016
-
11/2014 |
3 | Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
06/2024
-
03/2010 |
3 | Volatile Oils (Essential Oils)IBA
05/2024
-
10/2021 |
3 | Glucose (Dextrose)FDA LinkGeneric
02/2023
-
05/2007 |
3 | Matrix Metalloproteinases (MMPs)IBA
02/2023
-
11/2014 |
3 | CollagenIBA
01/2023
-
01/2018 |
3 | AntigensIBA
09/2022
-
09/2014 |
3 | Estrogen ReceptorsIBA
01/2022
-
01/2017 |
3 | Immunoglobulins (Immunoglobulin)IBA
01/2022
-
11/2014 |
3 | 2,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (AITC)IBA
11/2021
-
04/2017 |
3 | ImipenemFDA Link
01/2021
-
11/2019 |
3 | Immunoglobulin E (IgE)IBA
01/2021
-
01/2012 |
3 | Evans Blue (Blue, Evans)FDA Link
01/2020
-
01/2006 |
3 | CateninsIBA
01/2019
-
01/2011 |
3 | Proliferating Cell Nuclear Antigen (PCNA)IBA
12/2014
-
08/2002 |